Medical Safety & Global Health
Open Access

USA

Publications

• Extended Abstract   
  Regulatory Affairs 2020: Counterfeit drugs and medical devices in developing countries-Mark Willis, Pharmaceuticals and Medical Device Industry, US
  Author(s): Mark Willis
  
  The World Health Organization has reported that counterfeit medicines potentially make up more than 50% of the global drug market, with a significant proportion of these fake products being encountered in developing countries. This occurrence is attributed to a lack of effective regulation and a weak enforcement capacity existing in these countries, with an increase in this trade resulting from the growing size and sophistication of drug counterfeiters. In addition, due to both cost and lack of availability of medicines, consumers in developing countries are more likely to seek out these inexpensive options. The World Health Organization is mindful of the impact of counterfeit drugs on consumer confidence in health care systems, health professionals, the supply chain, and genuine suppliers .. View More»
  

  Abstract PDF